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Newly emerging influenza A viruses (IAV) pose a major threat to human health by causing seasonal 
epidemics and/or pandemics, the latter often facilitated by the lack of pre-existing immunity in the 
general population. Early recognition of candidate pandemic influenza viruses (CPIV) is of crucial 
importance for restricting virus transmission and developing appropriate therapeutic and prophylactic 
strategies including effective vaccines. Often, the pandemic potential of newly emerging IAV is only 
fully recognized once the virus starts to spread efficiently causing serious disease in humans. Here, 
we used a novel phylogenetic algorithm based on the informational spectrum method (ISM) to 
identify potential CPIV by predicting mutations in the viral hemagglutinin (HA) gene that are likely 
to (differentially) affect critical interactions between the HA protein and target cells from bird and 
human origin, respectively. Predictions were subsequently validated by generating pseudotyped 
retrovirus particles and genetically engineered IAV containing these mutations and characterizing 
potential effects on virus entry and replication in cells expressing human and avian IAV receptors, 
respectively. Our data suggest that the ISM-based algorithm is suitable to identify CPIV among IAV 
strains that are circulating in animal hosts and thus may be a new tool for assessing pandemic risks 
associated with specific strains.
Influenza A viruses (IAV) have their natural reservoir in aquatic birds. However, they may acquire muta-
tions that alter viral host tropism, leading to efficient replication in and/or transmission to other species 
including humans. The major potential of IAV to cause seasonal epidemics or pandemics is linked to 
their genomic variability. A high number of mutations results from the error-prone RNA-dependent 
RNA polymerase during viral RNA replication (antigenic drift). Furthermore, reassortment of genome 
segments may occur upon co-infection of the same cell by two or more different virus strains, often 
1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Str. 42-44, Frankfurt, 
Germany. 2Institute of Medical Virology, Justus Liebig University Giessen, Schubertstrasse 81, Giessen, Germany. 
3Center of Scientific Excellence for Influenza Viruses, National Research Centre (NRC), Dokki, Giza, Egypt. 4Robert-
Koch-Institute, Division for HIV and other Retroviruses, Nordufer 20, Berlin, Germany. 5Centre for Multidisciplinary 
Research, Institute of Nuclear Sciences VINCA, Mihaila Petrovica 14, Belgrade, Serbia. †Present address: B.Braun 
Melsungen AG, Carl-Braun-Str. 1, Melsungen, Germany. ‡Present address: AB Enzymes GmbH, Feldbergstrasse 
78, Darmstadt, Germany. *These authors contributed equally to this work. #These authors jointly supervised this 
work. Correspondence and requests for materials should be addressed to S.P. (email: stephan.pleschka@viro.
med.uni-giessen.de)
Received: 25 November 2014
Accepted: 27 May 2015
Published: 19 June 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:11434 | DOi: 10.1038/srep11434
resulting in viruses with reassorted genomes and profoundly changed antigenic and biological proper-
tie1–3. These genetic changes may cause immune escape from pre-existing neutralizing antibodies, resist-
ance to antiviral drugs as well as changes in host tropism and/or replication efficiency in specific hosts. In 
addition, “candidate pandemic influenza viruses” (CPIV) may emerge from avian reservoirs and evolve 
into viruses that are efficiently transmitted among humans. Such pandemic strains often carry mutations 
in the viral hemagglutinin (HA), the virus glycoprotein that mediates binding to the cellular receptor. In 
some cases, amino acid (aa) substitutions in the HA cause a change in receptor usage from an avian-type 
receptor (α 2,3-linked sialic acid, α 2,3-SA) to a human-type receptor (α 2,6 linked sialic acid, α 2,6-SA), 
resulting in variants that are efficiently transmitted in humans4,5. Furthermore, aa substitutions in the HA 
cleavage site and/or other viral proteins may enhance the pathogenicity of newly evolved virus strains 
in specific hosts6–11.
Pandemic strains of IAV that encounter populations with limited pre-existing immunity may cause 
significant mortality and economic damage, especially if there is a delay between the identification and 
characterization of a new IAV strain and the production and licensing of a matching vaccine. The previ-
ous century has seen several major pandemics, including the 1918 Spanish flu (caused by an IAV H1N1 
strain resulting in more than 50 million deaths), the 1957 Asian flu (H2N2, 1.5 million deaths), the 
1968 Hong Kong flu (H3N2, 1 million deaths) and the 2009 Mexican flu (H1N1, 18,000 deaths)10,12,13. 
Other IAVs, such as the highly pathogenic avian influenza A viruses (HPAIV) of the H5N1 subtype, 
are transmitted less efficiently in humans but feature extremely high case-fatality ratios of close to 60%. 
These viruses were first detected in humans in 1997 in Hong Kong, where six fatalities occurred due 
to infection with avian H5N1-type IAV14,15. After several years with sporadic outbreaks, a second and 
main wave of infections with H5N1 viruses started in 2003 in some Asian countries, which then spread 
to Europe, the Middle East and Africa16,17. In 2006, first human infections occurred in Egypt, with spo-
radic infections being reported in the following years18. From 2003 until March 3rd 2015, a total of 784 
cases of human H5N1 infections were reported worldwide (292 in Egypt), leading to 429 deaths (99 in 
Egypt)19. Since 2006, clade 2.2 H5N1 viruses have evolved in Egypt by antigenic drift, resulting in distinct 
endemic subclades with altered virulence, pathogenicity, transmission, receptor-binding preference and 
drug resistance profile20.
Specific bioinformatic algorithms may provide tools to monitor genetic changes in circulating IAV 
strains, including H5N1 HPAIV, and identify IAV strains posing an increased pandemic risk, especially 
in geographic regions where HPAIV are endemic and frequently transmitted to humans. In this context, 
we recently described a novel phylogenetic algorithm based on the informational spectrum method 
(ISM)21–23.
In the ISM approach, sequences (protein or nucleotide) are transformed into signals by assigning a 
numerical value to each element (amino acid or nucleotide). These values correspond to the electron - 
ion interaction potential (EIIP), which determines electronic properties of amino acids and nucleotides. 
The signal obtained is then decomposed into a periodical function by Fourier transformation, resulting 
in a series of frequencies (F) and their amplitudes (A). The obtained frequencies correspond to the distri-
bution of structural motifs with defined physico-chemical characteristics that are responsible for the bio-
logical function of the sequence. When comparing proteins that share the same biological or biochemical 
function(s) this technique allows the detection of code/frequency pairs that are specific for their common 
biological properties. The method is insensitive to the location of the motifs and, thus, does not require 
previous alignment of the sequences. The ISM was successfully applied to predict the biological function 
of novel proteins, in structure/function analyses of different protein and DNA sequences and in de novo 
design of biologically active peptides (http://www.vin.bg.ac.rs/180/anims/ISMEIIP_Approach.html).
The calculation of the informational spectra (IS) of IAV HA aa sequences allowed us to identify min-
imal changes (single or combined aa substitutions) that likely affect interactions of the viral HA protein 
with the cellular receptor24. We previously used this algorithm to monitor in silico the human tropism of 
highly pathogenic H5N1 viruses isolated in Egypt21.
In the present study, we extended the ISM analysis to H5-HA sequences of circulating viruses to 
identify aa substitutions predicted to enhance the tropism to human hosts, thereby possibly affecting 
the respective viruses’ pandemic potential. ISM analysis of H5N1 HA1 sequences of HPAIV circulating 
between 2006 and 2014 in Egypt suggested that the mutations K153D, S223N and G272S may signifi-
cantly increase the affinity of these viruses towards the human receptor. This is based on the observed 
increase in amplitude at the frequency (F) 0.236, representing the interaction with human cells, which 
is accompanied by a reduction in amplitude at F0.076, representing the interaction with avian cells. 
To validate our conclusions derived from these in silico studies, we generated replication-incompetent 
HA-pseudotyped retroviral particles (PRP) expressing H5-HA proteins with the respective codon sub-
stitutions (single or combined) and studied the entry of these PRPs into cells overexpressing human 
HA receptors in vitro. To further corroborate this set of data, recombinant IAV carrying equivalent 
substitutions in their HA genes were generated and their replication was analyzed in cell culture. As 
a safety measure, the multibasic HA-cleavage site present in the pathogenic H5-HA was replaced by a 
monobasic cleavage site in both the wildtype construct (Wt-LP IAV) and the mutants, resulting in viruses 
that required trypsin for fusion activity. Viruses carrying the specific HA substitutions were found to 
replicate more efficiently in mammalian cells overexpressing receptors for human HA, when compared 
to the parental Wt-LP IAV.
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Interestingly, our analyses of H5N1 HPAIV isolates collected in Egypt over the past few years revealed 
a strong increase in prevalence of the predicted mutations in the HA coding sequences. Also, the pre-
dictions and hypotheses derived from our in silico analysis combined with our subsequent experimental 
studies to validate these predictions are in line with the recent natural evolution of IAV in Egypt. Thus, 
a fairly consistent picture arises with respect to mutations that may play a role in the adaption of avian 
IAV to the human receptor. The available evidence leads us to suggest that Egyptian H5N1 HPAIV are 
evolving towards increased human tropism, a prerequisite for increased pandemic potential of these 
viruses. Our study illustrates the power of bioinformatic approaches in making early predictions on 
possible adaptation of specific strains to new hosts and the emergence of CPIV.
Materials and Methods
Cells and viruses. Madin-Darby canine kidney cells (MDCK-II), human lung adenocarcinoma epithe-
lial cells (A549), MDCK-SIAT1 cells (MDCK cells engineered to overexpress α 2,6 sialic acid transferase), 
human rhabdomyosarcoma (TE671) cells and human embryonic kidney cells (293T) were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Invitrogen) supplemented with 100 I.U./ml pen-
icillin, 100 μ g/ml streptomycin and 10% fetal bovine serum (FBS). Quail fibroblasts (QT6) were cul-
tured in Ham’s F10 medium (Gibco, Invitrogen) supplemented with 100 I.U./ml penicillin, 100 μ g/ml 
streptomycin, 2 mM L-glutamine, 10% tryptose phosphate broth, 5% chicken serum, and 10% bovine 
calf serum. MDCK-, 293T-, A549-, TE671- and QT6 cells were either obtained from the cell culture 
collection in Giessen or from LGC Promochem GmbH. MDCK-SIAT-1 cells were kindly provided by 
Mikhail Matrosovich, Institute of Virology, Philipps University, Marburg, Germany25. All cell monolay-
ers were incubated at 37 °C in the presence of 5% CO2. The HPAIV isolate A/Thailand/KAN-1/2004 
(KAN-1, H5N1) was kindly provided by P. Puthavathana, Thailand. Cells were infected at the indicated 
multiplicity of infection (MOI).
Characterization of avian and human HA receptor expression. To determine the abundance 
of specific sialic acid (SA) species (SAα 2,3Gal and SAα 2,6Gal) on the surface of MDCK-SIAT1, QT6 
and A549 cells, cell monolayers were fixed with 3% paraformaldehyde for 1 h at room temperature (RT) 
followed by 3 washing steps with PBS. Cells were incubated for 1 h at RT with fluorescein-labelled 
Sambucus nigra agglutinin (SNA, Biozol, Germany, 1:100 dilution) to detect α 2,6-SA or with biotiny-
lated Maackia amurensis lectin II (MAAII, Biozol, Germany, 1:100 dilution) to detect α 2,3-SA. Binding 
of biotinylated MAAII was visualized using streptavidin-Cy3 (Sigma-Aldrich, Germany) at a 1:500 dilu-
tion. Cell monolayers were washed with PBS and permeabilized with 0.2% Triton X-100 for 20 min. After 
another washing step with PBS, nuclei were stained with DAPI (4′ , 6′ -diamidino-2-phenylindole; 1:400 
dilution) (Roth, Germany) for 10 min at RT. Finally, cells were washed with PBS and water, embedded 
in Fluoromount-G (eBioscience, Germany) and analyzed by confocal laser-scanning microscopy (Leica 
TCS SP5).
Moreover, the presence of α 2,3- and α 2,6-linked SA on A549, QT6 and MDCK-SIAT1 cells was 
measured by FACS using different concentrations of biotinylated lectins MAAII (α 2,3-SA specific) and 
SNA/EBL (α 2,6-SA specific), respectively, and PE-conjugated streptavidin. Briefly, 106 cells were incu-
bated with 10–100 ng of the biotinylated lectins for 30 min at 4 °C. After washing in PBS, cells were 
stained with PE-conjugated streptavidin (1:500) for 30 min at 4 °C, washed again and PE-positive cells 
were quantified by flow cytometry (FACS Calibur, Becton Dickinson).
In silico prediction of HA mutations with pandemic potential. For in silico prediction of muta-
tions in H5-HA that might affect IAV cell tropism we analyzed the HA protein of KAN-1 by ISM, a vir-
tual spectroscopy method for structure/function analysis of proteins26,27. ISM is based on the assumption 
that the protein-protein interaction encompasses two basic steps: (i) recognition and targeting between 
interacting proteins (long-range interactions at distances > 5Ả) and (ii) chemical binding (short-range 
interactions at distances < 5Ả)27. The long-range interaction properties of biological molecules are deter-
mined by the electron-ion interaction potential (EIIP) representing the main energy term of valence 
electrons22. The EIIP for organic molecules can be calculated by the following simple equation derived 
from the “general model pseudopotential28”:
= . ( . π )/ π ( )⁎ ⁎ZW 0 25Z sin 1 04 2 1
where Z* is the average quasivalence number (AQVN) determined by:
Σ= / ( )Z ni* Zi N 2m
where Zi is the valence number of the i-th atomic component, ni is the number of atoms of the i-th 
component, m is the number of atomic components in the molecule, and N is the total number of atoms. 
Applying the given equations (1) and (2) to 20 amino acids, the following EIIP values are obtained 
(in Ry): L 0.0000, I 0.0000, N 0.0036, G 0.0050, V 0.0057, E 0.0058, P 0.0198, H 0.0242, K 0.0371, A 
0.0373, Y 0.0516, W 0.0548, Q 0.0761, M 0,0823, S 0.0829, C 0.0829, T 0.0941, F 0.0946, R 0.0959 and D 
0.1263. The ISM technique is based on a model of the primary structure of a protein using a sequence 
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of numbers, by assigning to each amino acid the corresponding EIIP value. The obtained numerical 
sequence, representing the primary structure of a protein, is then subjected to a discrete Fourier trans-
formation, which is defined as follows:
∑( ) = ( ) , = , , . …, / ( )− ( / )x eX n m n 1 2 N 2 3j 2 N nm
where x(m) is the m-the member of a given numerical series, N is the total number of points in this 
series, and X(n) are discrete Fourier transformation coefficients. These coefficients describe the ampli-
tude, phase and frequency of sinusoids, which comprised the original signal. The absolute value of a 
complex discrete Fourier transformation defines the amplitude spectrum and the phase spectrum. The 
complete information about the original sequence is contained in both spectral functions. However, in 
the case of protein analysis, relevant information is presented in an energy density spectrum23, which is 
defined as follows:
( ) = ( ) ( ) = ( ) , = , , . …, / ( )⁎X X nS n n X n n 1 2 N 2 42
In this way, sequences are analyzed as discrete signals. It is assumed that their points are equidistant 
with the distance d = 1. The maximal frequency in a spectrum (as defined above) is F = 1/2d = 0.5. The 
frequency range is independent of the total number of points in the sequence. The total number of points 
in a sequence influences only the resolution of the spectrum. The resolution of the N-point sequence is 
1/n. The n-th point in the spectral function corresponds to a frequency f(n) = nf = n/N. Thus, the initial 
information defined by the sequence of amino acids can now be presented in the form of an informa-
tional spectrum (IS), representing a series of frequencies and their amplitudes.
The IS frequencies correspond to the distribution of structural motifs with defined physicochemical 
properties determining a biological function of a protein. When comparing proteins that share the same 
biological or biochemical function, the ISM technique allows detection of code/frequency pairs that (i) 
are specific for their common biological properties or (ii) correlate with their specific interaction(s). 
These common informational characteristics of sequences are determined by the cross-spectrum or the 
consensus informational spectrum (CIS). A CIS of N spectra is obtained by the following equation:
pi( ) = ( , ) ( )S i jC j 5
where Π (i,j) is the j-th element of the i-th power spectrum and C(j) is the j-th element of CIS. Thus, CIS 
is the Fourier transform of the correlation function for the spectrum. Therefore, any spectral component 
(frequency) that is not present in all the compared informational spectra is eliminated. Peak frequencies 
in CIS represent the common information encoded in the primary structure of the analyzed sequences. 
This information corresponds to the mutual long-range interaction between analyzed proteins or their 
interaction with the common interactor.
ISM analysis allows: (i) to predict the biological function of a protein; (ii) to compare the biological 
activity within a group of proteins with the same function; (iii) to predict mutations that may increase 
or decrease the biological activity of a protein; (iv) to design an artificial protein sequence with a desired 
biological function.
The web tool for the calculation of informational spectra of proteins is available at: http://www.vin.
bg.ac.rs/180/istree/ and sequences of the different HA versions can be found in the supplementary infor-
mation.
Cloning and mutagenesis of HA. The H5-HA gene of KAN-1 was amplified by reverse RT-PCR 
from viral RNA isolated from virus-containing supernatants of infected MDCK cells. The HA sequence 
was amplified using primers Xma-HA-U (5′ -TATTCCCGGGAGCAAAAGCAGGGG-3′ ) and Xma-HA-L 
(5′ -ATATCCCGGGAGTAGAAACAAGGGTGTTTT-3′ ) and cloned via XmaI into a pHCMV-based 
vector as previously described29, resulting in M288-H5-HA. Single amino acid changes were introduced 
into M288-H5-HA by site-directed mutagenesis (quick change kit from Agilent Technologies). Double 
and triple mutations were introduced consecutively and all mutations were confirmed by sequencing.
Generation of H5-HA-pseudotyped retroviral particles (PRP). To generate replication-incompetent 
HA-PRP for single-round infection assays, we cloned (in addition to our HA constructs) the 
NA and M genes of KAN-1 into the M288 vector, resulting in M288-H5-NA and M288-H5-M. 
Primers for NA were Xma-NA-U (5′ -TATTCCCGGGAGCAAAAGCAGGAGT-3′ ) and Xma-NA-L 
(5′ -ATATCCCGGGAGTAGAAACAAGGAGTTTTT-3′  ) and for M Xma-M-U (5   ′ -TATTCCCGG 
GAGCAAAAGCAGGTAG-3 ′)  and Xma-M-L (5′ -ATATCCCGGGAGTAGAAACAAGGTAGTTTTT-
3  ′ ). Oncoretroviral PRP were essentially prepared as described previously29. Briefly, the three plasmids 
M288-H5-HA, M288-H5-NA and M288-H5-M (1 μ g each) were cotransfected with the MLV GagPol vector 
(pSV-Mo-MLVgagpol30 M579 (12.5 μ g)) and the GFP transfer vector (pMP71-eGFP-pre31 M56a (7.5 μ g)) 
into 293T cells (6 × 106 cells per 10 cm diameter dish) by calcium phosphate transfection. At 6 h posttrans-
fection (p.t.), the transfection medium was replaced with DMEM containing 10% FCS, 2% L-glutamine, 
100 I.U./ml penicillin, 100 μ g/ml streptomycin. PRP-containing supernatants were harvested at 48 and 72 h 
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p.t. After filtration (0.45 μ m filter), PRPs were concentrated by low speed centrifugation (16 h, 6,000 rpm, 
4 °C), resuspended in PBS and aliquots stored at –80 °C until further use.
Electron microscopy of H5-HA PRP. Two days p.t., cells were fixed with 2.5% glutaraldehyde in 
0.05 M Hepes (pH 7.2). Then, cells were scraped off, centrifuged, post-fixed with OsO4 (1%), block-stained 
with uranyl acetate (2%), dehydrated stepwise in graded alcohol, immersed in propylenoxide and embed-
ded in Epon (Serva, Heidelberg) with polymerisation at 60 °C for 48 h. Ultra-thin sections (60–80 nm) 
were cut using an ultramicrotome (Ultracut S or UCT; Leica, Germany) and stained with 2% uranyl 
acetate and lead citrate. Transmission electron microscopy was performed using an EM 902 (Zeiss) 
operated at 80 kV. Images were digitized using a slow-scan charge-coupled-device camera (Pro Scan; 
Scheuring, Germany).
Determination of receptor specificity of mutant H5-HA PRP. Mutant H5-HA PRP were titered 
on A549 cells, which express sialic acid receptors for human as well as avian IAV. Briefly, 5 × 104 cells 
were seeded in the wells of a 24-well plate. The next day, cells were incubated in duplicate with dilutions 
(0.1–20 μ l) of the appropriate mutant PRP stock. After three days, transduction rates were determined 
by quantifying GFP-positive cells by flow cytometry (FACS Calibur, Becton Dickinson). PRP titers were 
calculated as:
=
%
× ×
( ) ( )
infectious particles
ml
positive cells
100
number of cells 1
virus amount ml 6
To compare potential differences in receptor selectivity of the different HA mutants, equal amounts of 
the respective PRPs (MOI = 0.2 as determined on A549 cells) were added to QT6 cells, which predom-
inantly express the α 2,3-SA receptor bound by avian HA, and MDCK-SIAT1 cells, which also express 
the avian receptor, but overexpress the α 2,6-SA receptor bound by human HA25. Transduction rates of 
the two cell lines with the different mutant HA-PRPs were determined by quantifying GFP-positive cells 
by flow cytometry. Differences in receptor usage were determined by comparing relative numbers of 
GFP-positive cells determined on both cell lines (MDCK-SIAT1/QT6) using wildtype and mutant PRP, 
respectively.
3D structure model of the HA1 protein of IAV A/Thailand/1(KAN-1)/2004(H5N1). The 
structural model of the H5 HA molecule of KAN-1 was constructed using SWISS-MODEL32 and 
POLYVIEW-3D33 and is based on homology modeling using the crystal structure of the H5-HA protein 
of A/Vietnam/1203/2004 (PDB ID: 2FK0.1) as a template34. H5 numbering was based on the mature 
protein (Gene bank accession: AAS65615.2) and the residues involved in receptor binding were defined 
according to Duvvuri et al.35.
Generation of H5-HA IAV with a monobasic cleavage site. The reverse genetic sys-
tem encoding the 8 viral segments of HPAIV strain A/Thailand/KAN-1/2004 (KAN-1, H5N1) 
was kindly provided by Stephan Ludwig, Muenster, Germany. To clone the H5-HA gene encod-
ing the monobasic cleavage site, a cDNA to be used as template in subsequent PCRs was gen-
erated using the Uni-12 primer36. The multibasic cleavage site PQRERRRKKR/GLF between 
HA1 and HA2 was mutated to a monobasic cleavage site, PQRETR/GLF, using specific primers 
to amplify HA1: Ba-LPAI-F1 (5′ -TATAGGTCTCAGGGAGCAAAAGCAGGGGTTCAATC-3′ ) and 
Ba-LPAI-R1 (5′ -TATTGGTCTCTGTCTCTCTTTGAGGGCTATTTCTG-3′ ) and to amplify HA2: 
Ba-LPAI-F2 (5′ -TATCGGTCTCAAGACGAGAGGATTATTTGGAGCTAT-3′ ) and Ba-LPAI-R2 
(5′ -ATATGGTCTCGTATTAGTAGAAACAAGGGTGTTTTT-3′ ). Briefly, 2 μ l cDNA were mixed 
with 25 μ l 2x “Phusion Master Mix” (Thermo Scientific, USA), 2 μ l of each primer (40 pmoles each), 
and the total volume was adjusted to 50 μ l using nuclease-free water (Ambion, USA). The PCR 
reactions were then subjected to a pre-denaturation step at 98 °C for 30 sec, followed by 35 amplifi-
cation cycles (98 °C/10 sec, 58 °C/30 sec and 72 °C/1.5 min) and a final extension at 72 °C/5 min. The 
PCR products were purified using the “GeneJET Gel Extraction Kit” (Thermo Scientific, USA) and 
digested with BsaI-HF (NEB, Germany). The digested and purified PCR products were ligated with 
AarI-digested pMPccdB DNA as previously described37 and transformed into E. coli DH5α (New 
England Biolabs, USA).
A part of the HA1 sequence of monobasic KAN-1/HA cloned into pMPccdB was replaced with the 
corresponding sequences from the appropriate M288-H5-HA mutant constructs (Mut-I: S223N and 
G272S; Mut-II: K153D and S223N; Mut-III: K153D, S223N and G272S) using Mva1269I and EcoRI 
(Thermo Scientific, USA). The dual-promotor plasmids with mutated monobasic HA were transformed 
into competent E. coli XL-1 blue, screened, sequenced and then used for transfection (“NucleoBond® 
Xtra Maxi”; Macherey-Nagel, Germany).
Generation of IAV stocks and determination of replication kinetics. To generate the KAN-1 
(Wt-LP) virus and its mutant counterparts, 8 μ g of plasmid DNA (1 μ g of each plasmid) encoding 
the eight viral segments were transfected into a co-culture of 293T/MDCK-II cells (ratio 3:1, 10 cm2) 
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as previously described with minor modifications37–39. Briefly, the transfection mixture consisting of 
180 μ l “Opti-MEM” (Gibco, Invitrogen, USA), 8 μ g of plasmid DNA (1 μ g of each plasmid), and 16 μ l 
“Trans-IT2020” (Mirus, USA) was incubated for 45 min at RT. The transfection mixture was then diluted 
to 1 ml using Opti-MEM and transferred to an 80–90% confluent cell monolayer to allow transfection. 
The cells were then incubated for 8 h at 37 °C in the presence of 5% CO2. The transfection medium was 
replaced with 1 ml of infection medium (“Opti-MEM” containing 100 I.U./ml penicillin, 100 μ g/ml strep-
tomycin and 0.2% BSA (PAA, Germany)) and cell cultures were incubated for another 12 h. Then, an 
additional 1 ml of infection medium containing 2 μ g/ml TPCK-treated trypsin was added (Sigma-Aldrich, 
USA). The cell culture supernatant was harvested 48 h after addition of the TPCK-treated trypsin and 
cell debris was removed by centrifugation at 2500 rpm for 5 min at 4 °C. An aliquot of 500 μ l of each 
supernatant was used to inoculate fresh MDCK-II cells (25 cm2) and cultures were incubated for 72 h in 
the presence of TPCK-treated trypsin (1 μ g/ml). Titers of recombinant viruses were determined as FFU/
ml in MDCK-II cells40.
To determine multi-step growth curves, confluent monolayers of A549, QT6 and MDCK-SIAT1 cells, 
respectively, were each infected in triplicate with KAN-1 (Wt-LP) and its mutant derivatives, respectively, 
at an MOI of 0.001 FFU/cell. After 1 h of incubation at RT, the medium was replaced with infection 
medium (minimal essential medium with 100 I.U./ml penicillin, 100 μ g/ml streptomycin, 0.2% BSA and 
1 μ g/ml TPCK-treated trypsin) and the cells were incubated at 37 °C. Supernatants were collected at 1, 
24, 36 and 48 h postinfection and stored at − 70 °C. Virus titers were determined by focus assay40.
Biosafety. All experiments with infectious virus were performed according to German regulations 
for the propagation of influenza viruses. All experiments involving highly pathogenic avian influenza A 
viruses were performed in a biosafety level 3 (BSL3) containment laboratory approved for such use by 
the local authorities (RP, Giessen, Germany).
Results
IS frequency analysis. According to the ISM concept, interactions between biological molecules 
encompass two steps: (i) specific recognition by interacting molecules (long-range interactions with dis-
tances between 5 and 1000 Å) and (ii) chemical binding (short-range interactions with distances < 5 Å). 
Without the first step the number of collisions between interacting molecules will be small, and without 
the second step the interacting molecules will fail to bind to each other. In conclusion, each of these two 
steps represents a “necessary but not sufficient” condition for efficient interaction between biological 
molecules measured by their “productive collision”.
As was demonstrated previously for an efficient interaction, the protein domains, which are essential 
for recognition and targeting (recognition and targeting site, RTS) and the receptor binding domain 
(RBD), should be located close to each other41. Specific long-range interactions between proteins are rep-
resented by the common frequency components in their informational spectrum (IS), and the strength 
of the interaction is represented by the amplitude values on this frequency. This common frequency is 
determined by a peak in the cross-spectrum of proteins (CS). The presence of a common frequency 
component in the IS of a group of proteins suggests that these proteins have common interactor char-
acteristics.
Mutations that decrease the amplitude value of the IS frequency (responsible for long-range interac-
tion between proteins) decrease the efficacy of protein interactions by decreasing the efficacy of their rec-
ognition and targeting resulting in a decreased number of productive collisions. Conversely, mutations 
that increase this amplitude increase the efficacy of protein-protein interactions. Therefore, mutations 
that affect the amplitude on a characteristic frequency, although located outside the chemical RBD, also 
affect the efficacy of protein-protein interactions.
We previously showed that HA1 from H5N1 HPAIV that predominantly interact with the avian 
receptor are characterized by the IS frequency F(0.076), whereas HA1 from viruses that preferentially 
infect humans are characterized by the frequency F(0.236)41. Thus, the amplitude values of F(0.076) 
and F(0.236) can be used as indicators of the respective viral tropism (bird versus human). A ratio of 
A(0.236)/A(0.076) < 1 suggests that the virus preferentially infects birds. Conversely, A(0.236)/A(0.076) 
> 1 suggests that the virus is more likely to infect humans. Therefore, mutations in the H5N1 HA1 that 
decrease the amplitude F(0.076) and/or increase the amplitude F(0.236) are predicted to improve the 
recognition of the human receptor, leading to a virus that, most likely, infects humans more efficiently. 
In other words, increased A(0.236)/A(0.076) ratios indicate that viruses expressing the respective HA1 
protein are more likely to infect humans.
In line with this, a recent analysis of mutations in H5N1 viruses circulating in Egypt between 2006 
and 2012 revealed a total of 10 aa substitutions (P74S, H110R, A127T, F143Y, K153D, S188K, S223(N/I), 
S234P, G272S, N275S) that lead to a significant increase of the A(0.236)/A(0.076) ratio21,41. Importantly, 
the prevalence of a specific G272S replacement (that also occurred in combination with S223N) increased 
over time. Interestingly, these aa substitutions are highly specific for Egyptian H5N1 viruses and not 
conserved or very rare in the HA proteins of viruses isolated in other parts of Africa or in Europe and 
America. To obtain further evidence for a potentially increased pandemic risk associated with H5N1 
HPAIV carrying these mutations, we characterized the respective mutations in the structural context 
of an HA of an IAV strain from another geographical region. To this end, we introduced 10 mutations 
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(alone and/or in combination) into the HA coding sequence of the prototype Asian strain A/Thailand/
KAN-1/2004 (KAN-1, H5N1) and determined the A(0.236)/A(0.076) amplitude ratios (Supplementary 
Table S2). Among all the mutations tested, K153D, S223(N,I) and G272S were found to increase the 
amplitude at the frequency F(0.236) most profoundly, the latter representing the frequency determined 
for human-adapted IAV strains (Fig. 1). The amplitude increase at F(0.236) was linked to an amplitude 
reduction at F(0.076), indicating an improved interaction with the avian receptor. The A(0.236)/A(0.076) 
ratio was found to be increased from 0.77 to 1.26, suggesting an increased pandemic potential for viruses 
carrying these mutations (see above). As indicated above, the prevalence of the G272S mutation in 
H5N1-HA sequences isolated from virus strains circulating in Egypt has strongly increased since 2009, 
particularly in viruses isolated from humans (from 5.6% in 2009 to 95.7% in 2011, see Supplementary 
Table S1). Furthermore, the (only) two HA sequences determined in 2012 for Egyptian isolates of human 
HAPIV were shown to carry the double mutation G272S/S223N.
Generation of H5-HA wildtype and mutant pseudotyped retroviral particles (PRP). To cor-
roborate the predicted role of specific HA mutations in human receptor usage, we introduced the appro-
priate mutations into the KAN-1 HA sequence and studied potential effects on virus entry in two cell 
lines that either express avian or human receptors. We first generated retroviral particles pseudotyped 
with wildtype KAN-1/HA or mutant forms of HA carrying the mutations predicted by ISM to confer 
higher preference for α 2,6-SA (Table  1). Pseudotyped retroviral particles (PRP) were generated from 
293T cells transfected with a plasmid expressing wildtype and mutant H5-HA, respectively, and a set 
of plasmids expressing the NA and M proteins of KAN-1, MLV GagPol and the GFP marker protein, 
respectively. PRP infectivity was confirmed by FACS analysis of GFP expression after transduction of 
A549 cells with supernatants of transfected cells (Fig. 2a).Titers of the different wildtype and mutant PRP 
stocks determined on A549 cells varied between 2.4 × 104/ml and 2.3 × 107/ml (Table  1). Thin-section 
electron microscopy of transfected 293T producer cells revealed the expected morphology of immature 
Figure 1. Effects of combined mutations K153D, S223N and G272S in H5-HA of A/Thailand/KAN-
1/2004 (KAN-1) on the informational spectra (IS). a) IS of HA1 of the wildtype KAN-1 virus, b) IS of 
HA1 from the KAN-1 virus-derived triple mutant. Frequencies at 0.076 and 0.236 for avian and human 
receptor specificity are indicated.
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WT 5.1 × 105/ml
K153D 2.2 × 106/ml
S223N 8.3 × 106/ml
G272S 3.5 × 106/ml
K153D/S223N 2.4 × 104/ml
K153D/G272S not analyzed
S223N/G272S 2.3 × 107/ml
K153D/S223N/G272S 4.3 × 105/ml
Table 1.  Infectious titers of the different HA pseudotyped retroviral particles on A549 cells.
Figure 2. Characterization of HA-pseudotyped KAN-1 wildtype PRPs. a) FACS analysis of eGFP 
expression in A549 cells untransduced (left) or transduced (right) with wildtype HA/NA/M/eGFP 
pseudotyped retroviral particles. b) Electron microscopic images of wildtype H5N1 PRPs produced from 
293T cells. A free immature PRP (left panel), as well as a mature PRP (right panel) are marked by an arrow. 
An electron lucent core characterizes the immature particle on the left panel, whereas the more mature 
particle on the right panel has an electron dense core.
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and mature PRPs as well as budding structures (Fig. 2b). The retroviral particles displayed a dense enve-
lope layer suggesting efficient expression and incorporation of the IAV surface proteins.
Determination of the receptor specificity of mutated H5-HA PRP. To investigate if the HA 
mutations improve α 2,6-SA receptor usage (as suggested by the ISM analysis, see above), we analyzed 
the infectivity of the corresponding mutant PRP on cells expressing different amounts of α 2,3- and 
α 2,6-SA (QT6, MDCK-SIAT1). QT6 is known to primarily express α 2,3-SA (the avian IAV-type recep-
tor), while MDCK-SIAT1 mainly expresses α 2,6-SA (the human IAV-type receptor). Expression levels of 
the two receptors were determined by differential lectin-binding analysis (Fig. 3). Varying concentrations 
of biotinylated lectins, MAAII specific for α 2,3-SA and SNA/EBL specific for α 2,6-SA, were added to the 
cells and cell-bound lectins were quantified by FACS analysis using PE-labelled streptavidine. A549 cells, 
which were used to determine the titers of our PRP stocks, were included as control (Fig. 3).
As expected, both types of lectins were bound by A549 cells at high levels, indicating good expression 
of both receptor types (Fig.  3a,b). In contrast, QT6 cells only bound to MAAII lectin, whereas SNA/
EBL binding was not detectable, not even at the highest lectin concentration used (100 ng) (Fig.  3b). 
MDCK-SIAT1 cells were shown to bind both types of lectins, indicating the presence of both receptors. 
However, the amount of α 2,6-SA was significantly increased compared to A549 control cells (Fig. 3b). 
The differential expression of both receptors on these cell lines was confirmed by confocal laser micros-
copy (Fig. 3c). Based on these observations, we decided to use QT6 cells (expressing predominantly avian 
IAV receptors) and MDCK-SIAT1 cells (overexpressing human IAV receptors) in subsequent differential 
infectivity experiments.
Potential differences in receptor usage by individual mutant PRPs (compared to the wildtype PRP) 
were assessed by determining the ratio between GFP-positive MDCK-SIAT1 and GFP-positive QT6 cells 
following transduction with equal amounts of wildtype and mutant PRP, respectively. All mutants pre-
dicted by ISM to result in increased α 2,6-SA usage showed better infectivity on MDCK-SIAT1 cells as 
reflected by increased MDCK-SIAT1/QT6 ratios compared to wildtype HA (Fig. 4). The double mutant 
S223N/G272S showed the highest MDCK-SIAT1/QT6 ratio, which was not further increased, but rather 
decreased, in the triple mutant K153D/S223N/G272S. Thus, the increased usage of human α 2,6-SA 
receptors by the mutations in HA predicted by ISM was experimentally confirmed as reflected by better 
infectivity of the corresponding mutant PRP on cells overexpressing the human receptor.
Replication kinetics of IAV HA mutants in MDCK-II cells. To assess potential effects of HA muta-
tions on viral replication, we used reverse genetics to produce and characterize a set of IAV mutants 
based on a genetically modified form of KAN-1 (designated Wt-LP) that (for biological safety reasons) 
lacked a multi-basic cleavage site in its HA protein (Fig. 5a). The mutant viruses derived from the paren-
tal Wt-LP virus carried the HA mutations that had been shown to cause the strongest effects in our PRP 
infectivity assays (see above) (M-I, M-II and M-III). Figure  5b,c indicate the location (in the globular 
head domain, HA1, of the molecule) of the three aa residues 153, 223 and 272 that we have analyzed.
Focus size and morphology were analyzed using MDCK-II cells (Fig. 6a) and the relative distribution 
of focus diameters was determined (Fig. 6b). The M-II virus (K153D, S223N) produced foci similar in 
size to those produced by the parental WT-LP virus, while foci produced by the M-I (S223N, G272S) 
and M-III (K153D, S223N, G272S) mutants were significantly larger than those of KAN-1 (Wt-LP). This 
indicates that the M-II and -III viruses have a propagation advantage in MDCK-II cells compared to 
the parental virus.
Replication of H5N1 IAV mutants in different cell types in vitro. The potential impact of the 
introduced HA mutations on viral replication was further investigated in (i) MDCK-SIAT1 cells, which 
overexpress α 2,6-SA25, (ii) QT6 cells, which overexpress α 2,3-SA, and (iii) A549 cells, which express 
similar amounts of α 2,3-SA and α 2,6-SA (Fig. 3). Confluent cell monolayers were infected with paren-
tal or mutant viruses at an MOI of 0.001 FFU/cell and maintained in trypsin-containing cell culture 
medium. Virus titers in supernatants collected at 12, 24, 36 and 48 h p.i. were determined as FFU/ml on 
MDCK-II cells40. In MDCK-SIAT1 cells (Fig.  7a), the titersof all mutants were approximately 0.5 log10 
FFU/ml higher than that of the KAN-1 (Wt-LP) at 24–36 h p.i. However, at 48 h p.i., the M-III virus 
showed a significant increase in titer of about 1.0 log10 FFU/ml compared to both the parental KAN-1 
(Wt-LP) and the other two mutants (Fig. 7a). Conversely, in QT6 (Fig. 7b) and A549 (Fig. 7c) cells, the 
parental KAN-1 (Wt-LP) and M-III viruses replicated to similar titers with no apparent differences in 
infectious particle number. In contrast, M-I and -II virus titers were significantly reduced by 0.5–1.0 log10 
FFU/ml compared to the parental KAN-1 (Wt-LP) virus at 24–48 h p.i (Fig. 7b,c). Taken together, these 
results suggest that the triple mutation in HA (K153D/S223N/G272S; Mut-III) enhances viral replication 
in cells that overexpress α 2,6-SA (MDCK-SIAT1), while there was no such difference in A549 and QT6 
cells, which express low(er) amounts of α 2,6-SA (compared to MDCK-SIAT1). The double mutants, 
S223N/G272S and K153D/S223N (Mut-I, Mut-II), also replicated more efficiently in MDCK-SIAT1 cells. 
However, in this case, the increase was much less profound compared to the triple mutant. In A549 and 
QT6 cells, the double mutants replicated to lower titers compared to both the parental virus and the 
triple mutant, possibly indicating that the binding to α 2,3-SA was reduced in these mutants.
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Figure 3. Determination of α2,6- and α2,3 receptors on MDCK-SIAT1, A549 and QT6 cells with 
specific lectins. a,b) The binding of varying amounts of biotinylated lectins MAAII (specific for avian α 2,3 
receptors) and SNA/EBL (specific for human α 2,6 receptors) to QT6 and MDCK-SIAT1 cells as well as A549 
control cells was determined by FACS analysis using streptavidine-PE. The differences of binding of varying 
amounts of biotinylated lectins to different cell lines were statistically compared to QT6 for MAAII-lectin 
binding or A549 for SNA/EBL-lectin binding using two-way ANOVA, followed by Bonferroni post hoc test. 
Significant differences between data sets are indicated by asterisks (*), whilst (ns) indicates non-significant 
differences. c) Formaldehyde-fixed monolayers of the indicated cell types were incubated with fluorescein-
labelled SNA lectin to detect α 2,6-linked sialic acids and biotinylated MAAII lectin and streptavidin-Cy3 to 
detect α 2,3-linked sialic acids. The cellular membrane was permeabilized, the nuclei were stained with DAPI 
and analyzed using confocal microscopy.
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Discussion
H5N1-type HPAIV are associated with high mortality in humans (> 60%) and therefore represent a seri-
ous threat to human health. WHO launched extensive surveillance and monitoring programs for IAV42 
and the development of new tools for early detection of new strains and prevention of IAV pandemics 
is of high priority. To date, H5N1 viruses have not (yet) been transmitted efficiently among humans, 
but there is a risk of this host restriction being overcome by reassortment of genome segments between 
H5N1 and co-circulating human H1N1 or H3N2 IAV strains.
Recent studies suggest that H5N1 HPAIV isolated in Egypt over the past few years increasingly exhibit 
a receptor usage that is similar to that of seasonal human H1N1 viruses, possibly indicating more effi-
cient human-to-human transmission and increased pandemic potential in the (near) future24,43. An anti-
genic cartography of viruses isolated in Egypt revealed 6 distinct antigenic groups44. In line with our data 
and conclusions presented above, 19 of the 27 mutations presumably involved in adaptation of H5N1 
viruses to the human receptor are associated with an increase of the A(0.236)/A(0.076) ratio21. Others 
possibly increase the affinity of the HA to the human receptor by a better adaptation of the receptor 
binding domain (RBD).
In this study, we used the ISM bioinformatic tool to characterize a set of mutations in the H5-HA 
that likely increase the pandemic potential of a prototype HPAIV (KAN-1) strain. We found that the 
mutations, when introduced in silico into the wildtype KAN-1 HA sequence, led to an increase of the 
amplitude ratio A(0.236)/A(0.076) at the frequencies F at 0.236 and 0.076, the latter indicating critical 
interactions of HA with human and avian receptors, respectively (Fig. 1). The ratio increased from 0.77 
to 1.26, with values above 1 suggesting increased human tropism24. By comparison, the amplitude ratio 
increased only from 0.72 to 0.96 (Supplementary Fig. S1) if substitutions known to increase IAV trans-
mission by respiratory droplets in ferrets (N154D, Q222L, N220K, and T315I) were analyzed in the 
context of the HA protein of A/Vietnam/1203/2004 (H5N1)45.
In our ISM studies, the HA aa substitutions K153D, S223(N,I) and G272S (alone or in different 
combinations) increased the amplitude that indicates human receptor usage most profoundly (data not 
shown). Importantly, S223N and, particularly, G272S have also been detected in H5N1 HPAIVs circulat-
ing in Egypt and the number of viruses carrying these mutations has significantly increased since 2008 
(Supplementary Table S1), correlating with an increasing number of human H5N1 infections in this 
country. The fact that the number of human cases in Egypt did not increase more dramatically in recent 
years might reflect a need for further adaptive requirements, for example in the receptor binding domain. 
Interestingly, S223N substitutions were only detected in human samples and combinations of the two 
aa substitutions were detected in both human H5N1 HPAIV HA sequences reported in 2012, further 
supporting the significance of these aa substitutions in viral adaptation to human hosts and suggesting 
an increased pandemic potential for H5N1 HPAIV strains currently circulating in Egypt (Supplementary 
Table S1).
Substitutions at position 153 (150-Loop) and 223 (220-Loop) of the receptor-binding site in the glob-
ular head domain of H5-HA are expected to affect the structure of the receptor-binding site and, thus, 
may influence receptor specificity. Amino acid mutations K153R and S223N/G were shown to alter the 
antigenic properties and/or receptor specificity34,46–48. However, it is currently not clear if the recently 
Figure 4. Infectivity of wildtype and HA-mutated PRPs on QT6 and MDCK-SIAT1 cells. Equal 
numbers of MDCK-SIAT and QT6 cells, respectively, were transduced with the indicated PRPs at an MOI 
of 0.2 and GFP-positive cells were counted by FACS analysis at 72 h post transduction. The ratio of GFP-
positive MDCK-SIAT/QT6 cells is shown for the mutants compared to wildtype. Shown are the results of a 
representative experiment. The MDCK-SIAT/QT6 ratio was calculated from median values determined from 
triplicate cultures performed for each of the mutants.
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Figure 5. Location of the studied amino acid (aa) in the H5-HA of avian influenza A/
Thailand/1(KAN-1)/2004 (H5N1) virus. a) The schematic representation shows the relative locations of 
H5-HA mutations in HA1 at aa positions 153, 223 and 272 (indicated in blue). The multibasic protease 
cleavage site present in the original KAN-1 isolate was removed in all recombinant viruses generated in 
this study (Wt-LP and Mut-I to -III). SP: signal peptide; TM: transmembrane domain; CT: cytoplasmic tail. 
b) and c) 3D structure model of H5 HA1 (for details, see Materials and Methods). Amino acid residues at 
positions 153, 223 and 272 (blue, spheres) are shown in side and top view in relation to the receptor-binding 
sites (red side chains). The other 7 aa that were previously identified by ISM in H5N1 viruses circulating in 
Egypt between 2006 and 2012, which also increase the A(0.236)/A(0.076) ratio (74, 110, 127, 143, 188, 234, 
275), are shown as green side chains.
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reported adaptive substitution G272S in the H5-HA protein of Egyptian isolates has similar effects on 
the receptor specificity20. In a recent attempt to establish a model that predicts the evolution of the viral 
population, the analysis of 3,944 HA sequences from H3N2 IAV revealed that adaptive mutations, which 
influence biological and immunological properties of these viruses, occur with highest probability within 
the epitopes A–D49. The alterations at the three selected positions (153, 223, 272) investigated here are 
also located within epitopes A, B and C, suggesting that with high probability such variations can be 
expected to occur also in H5-type HA of HPAIV as a consequence of natural viral adaptation.
To provide more direct evidence for an involvement of specific HA aa residues in the adaptation to 
human receptor usage we made appropriate replacements (predicted by ISM to alter the amplitude ratio 
A(0.236)/A(0.076) towards human receptor usage) in the HA protein of the A/Thailand/KAN-1/2004 
(KAN-1) strain. Single or combined replacements of K153D, S223N and G272S were introduced into the 
H5-HA of KAN-1. Potential effects of the introduced aa substitutions were studied by using (i) retroviral 
particles pseudotyped with either the wildytpe or the respective mutant HAs and (ii) recombinant viruses 
based on an attenuated KAN-1 virus (WT-LP).
Transduction of PRPs expressing GFP and a wildtype or mutant form of HA into MDCK-SIAT1 
cells (overexpressing the human receptor type) and QT6 cells (with very low expression of the human 
receptor type) revealed an increased MDCK-SIAT1/QT6 ratio for all these mutants compared to wild-
type (Fig. 4), strongly supporting our ISM-based predictions on more efficient human receptor usage for 
these mutants. Notably, ISM analyses of double and triple mutations consistently showed a decrease in 
amplitude at the frequency for avian receptor usage (0.076) accompanied by an increase at the frequency 
for human receptor usage (0.236). This was more pronounced for the triple mutation (Supplementary 
Table S2). Even though the triple mutations substantially decreased the amplitude of the avian frequency 
compared to wildtype (Supplementary Table S2), the results shown in Fig.  7B indicate no decrease of 
viral replication in QT6 cells. We think that combinations of mutations do not only affect long-range 
interaction properties of HA1 but may also affect its 3D structure. For this reason, the triple mutation 
(even though it increases the calculated efficacy of recognition and targeting between HA1 and the 
human receptor) might not necessarily disturb the chemical binding to the avian receptor.
The PRP study was complemented by the characterization of recombinant viruses derived from 
KAN-1 (Wt-LP) that express different mutant forms of HA with combined replacements at positions 
153, 223 and 272 (K153D, S223N and G272S). The data show that mutants containing combined S223N 
and G272S replacements produce larger foci in mammalian MDCK cells (Fig.  6). Compared to the 
parental KAN-1 (Wt-LP) virus, viruses containing double or triple replacements replicated significantly 
more efficiently in MDCK-SIAT1 cells overexpressing α 2,6-SA (as determined by FFU/ml). In contrast, 
Figure 6. Focus phenotypes of recombinant KAN-1 (Wt-LP) and H5-HA mutant KAN-1 viruses on 
MDCK cells. a) Focus assay showing different focus sizes. MDCK-II cells were infected with the parental 
and mutated viruses at an MOI of 0.001 for 24 h and then stained using a monoclonal antibody against 
NP. b) Average focus sizes were determined from 50 foci for each virus. Asterisks (*) indicate a significant 
difference (p < 0.05) compared to the parental KAN-1 (Wt-LP) virus, while (ns) indicates non-significant 
difference. Statistical analysis was performed using one-way ANOVA, followed by Turkey’s post hoc test.
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differential growth kinetics of wt versus HA mutant viruses was not observed in cells expressing only 
the avian HA receptor type, indicating that these changes do not represent a propagation disadvantage 
in avian hosts.
Recent human infections with a low pathogenic avian influenza virus (LPAIV) of the H7N9-type 
have initiated a paradigm change50,51. Previously, studies into the pandemic potential for humans were 
largely focused on HPAIV of the H5N1 and H7N3/H7N7 subtypes. While H5N1 HPAIV are known to 
cause severe disease in humans and many birds, the H7-type is generally associated with mild disease in 
humans but causes fatal disease in a wide range of birds including economically relevant species (chicken, 
turkeys, etc.)52,53. However, recent work shows that also specific H7-type HPAIV strains have the poten-
tial to replicate in mammalian species40,54. These observations have led to more extensive research and 
Figure 7. In vitro growth kinetics of KAN-1 (Wt-LP) and H5-HA mutant KAN-1 viruses. a) MDCK-
SIAT1, b) QT6, or c) A549 cells were infected at an MOI of 0.001. The infectious virus and HA titers 
were determined at the indicated time points in MDCK-II cells by focus assay (FFU/ml) and standardized 
hemagglutination assay (HAU/ml). Mean values of results represent the averages from three independent 
experiments and are presented with standard deviations (SDs) indicated by error bars. Asterisks (*) indicate 
a significant difference (p < 0.05) compared to the parental KAN-1 (Wt-LP) virus while (ns) indicates a 
non-significant difference. Statistical analysis was performed using repeated measures ANOVA, followed by 
Bonferroni post hoc test.
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monitoring efforts to better understand the specific pathogenic and epidemiological characteristics of 
these HPAIV. Additionally, the large group of LPAIV and the recently documented H7N9, H10N8 and 
H6N1 LPAIV cases in humans extend the list of subtypes potentially causing human disease and thus 
deserve further studies55,56. The increasing number of cases with IAV subtypes not considered previously 
to cause disease in humans highlights the need to develop new tools (including in silico methods) that 
are suitable to closely monitor the biological properties (tropism, pathogenic potential in specific species, 
etc.) of circulating IAV strains and identify mutations indicative of CPIV. These tools might help the 
health authorities, healthcare systems, and vaccine manufacturers to plan ahead and respond earlier to 
newly emerging IAVs with pandemic potential. The bioinformatic method used in the present study to 
define mutations in H5N1 IAV that indicate viral adaptation to humans and thus increase the pandemic 
potential of these viruses may be a suitable tool to identify CPIV among circulating influenza viruses in 
different populations.
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